86.90.E - Other human health activities notelsewhere classified
46.46.Z - Wholesale of pharmaceutical goods
46.90.Z - Non-specialised wholesale trade
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.91.Z - Retail sale via mail order houses or via Internet
63.11.Z - Data processing, hosting and related activities
63.12.Z - Web portals
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
86.22.Z - Specialist medical practice activities
2019 | 2020 | 2021 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -500,2 | -22,8 | -26,3 | -15,7 |
EBITDA | -76,4 | -3,9 | -3 | 23,7 |
Short time liabilities | 64,7 | 70,3 | 78,7 | 12 |
Equity capital | -17,2 | -41,9 | -68,2 | -62,9 |
Operating profit (EBIT) | -494,9 | -21,6 | -20,7 | 4,3 |
Assets | 87,9 | 70,5 | 54,2 | -23 |
Net profit (loss) | -500,2 | -22,8 | -26,3 | -15,7 |
Cash | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 105,1 | 112,3 | 122,4 | 9 |
Net income from sale | 0 | 0 | 0 | 0 |
Working assets | 21,6 | 21,9 | 23,4 | 6,8 |
Depreciation | 418,5 | 17,7 | 17,7 | 0 |
% | % | % | p.p. | |
Profitability of capital | 2908,4 | 54,3 | 38,6 | -15,7 |
Equity capital to total assets | -19,6 | -59,4 | -125,7 | -66,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.33467918634414673 | 0.31211310625076294 | 0.2975768446922302 | 0 |
Net dept to EBITDA | -0.5285848379135132 | -10.722628593444824 | -14.61093521118164 | -3,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane